Literature DB >> 1830526

Prevalence and incidence of diabetes in a Swedish community 1972-1987.

D K Andersson1, K Svärdsudd, G Tibblin.   

Abstract

The prevalence and incidence of diabetes mellitus were studied from 1972 to 1987 in Laxå, a rural community with 8500 inhabitants located in mid-Sweden. Data were collected from clinical records at the primary health care centre in Laxå, from departments of internal medicine and paediatrics and from a general practitioner's office in the area. In addition, a case finding procedure involving 85% of the residents aged 35-79 years was performed in 1983-1987. The age-standardized prevalence of diabetes rose significantly (p less than 0.001) from 26 per 1000 in 1972 to 43 per 1000 in 1987. The largest rise in prevalence for males occurred in the age group 45-54 years and for females in the age group 65-74 years. The age-standardized mean annual incidence of diabetes was 3.46 per 1000 population. A small (non-significant) increase in incidence of Type 2 diabetes over time was seen in men which may in part be an effect of the case finding strategy. The overall incidence rates thus appeared to be rather stable while the prevalences tended to increase, probably mainly due to earlier detection of diabetic individuals in recent years, leaving a larger number of patients with a longer duration of diabetes to be cared for in the future.

Entities:  

Mesh:

Year:  1991        PMID: 1830526     DOI: 10.1111/j.1464-5491.1991.tb01626.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  17 in total

1.  Quality of life among diabetic patients in Swedish primary health care and in the general population: comparison between 1992 and 1995.

Authors:  P E Wändell; B Brorsson; H Aberg
Journal:  Qual Life Res       Date:  1998-12       Impact factor: 4.147

2.  Are Scots with hypertension at high risk of diabetes or impaired glucose tolerance?

Authors:  Jean Robson; Susan McGrouther
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

3.  Assessing sexual functioning in patients with chronic disorders by using a generic health-related quality of life questionnaire.

Authors:  P E Wändell; B Brorsson
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

4.  Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study.

Authors:  M P Garancini; G Calori; G Ruotolo; E Manara; A Izzo; E Ebbli; A M Bozzetti; L Boari; P Lazzari; G Gallus
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

5.  Accelerated progression from mild cognitive impairment to dementia in people with diabetes.

Authors:  Weili Xu; Barbara Caracciolo; Hui-Xin Wang; Bengt Winblad; Lars Bäckman; Chengxuan Qiu; Laura Fratiglioni
Journal:  Diabetes       Date:  2010-08-16       Impact factor: 9.461

6.  Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study.

Authors:  W L Xu; E von Strauss; C X Qiu; B Winblad; L Fratiglioni
Journal:  Diabetologia       Date:  2009-03-12       Impact factor: 10.122

7.  Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.

Authors:  C S Hampe; T R Hall; A Agren; O Rolandsson
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

8.  Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trøndelag diabetes study.

Authors:  K Midthjell; J Holmen; A Bjørndal; G Lund-Larsen
Journal:  J Epidemiol Community Health       Date:  1992-10       Impact factor: 3.710

9.  The use of hypoglycaemic and cardiovascular drugs in 582 patients with diabetes mellitus. Description and quality assessment.

Authors:  G Van den Brink; R R Schwartzenberg; L J Hoeve; A J Porsius; L L Hoeve
Journal:  Pharm World Sci       Date:  1993-06-18

10.  Diabetes as a risk factor for stroke. A population perspective.

Authors:  B Stegmayr; K Asplund
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.